Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 13INDUSTRY 2OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Conditions

Polycystic Ovary Syndrome 1Gonadal Disorders 1Endocrine System Diseases 1

Interventions

Cisplatin 50Capecitabine 42apatinib 34Radiotherapy 33Oxaliplatin 33Gemcitabine 33Cyclophosphamide 32Drug Therapy 31Paclitaxel 30Carboplatin 29tislelizumab 27Irinotecan 27Fluorouracil 26Docetaxel 26Bevacizumab 23Surgical Procedures, Operative 21Nivolumab 19pembrolizumab 18fludarabine 18Radiation 16Metformin 16Exercise 16camrelizumab 15S 1 (combination) 14Control Groups 14Blood Specimen Collection 14Pemetrexed 13Standard of Care 12anlotinib 11Neoadjuvant Therapy 11

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER_GOV × Chorionic Gonadotropin × Clear all
NCT00947713 2011-07-15

Comparison of Micro-dose Human Chorionic Gonadotropin (hCG) With Human Menopausal Gonadotropin (HMG) in Polycystic Ovary Syndrome

Royan Institute

Phase 1/2 Completed
10 enrolled

Endocrine System Diseases, Gonadal Disorders, Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡